[Lung cancer screening].

Prosch, H; Ebner, Lukas (2019). [Lung cancer screening]. Der Radiologe, 59(1), pp. 19-22. Springer 10.1007/s00117-018-0478-1

Preview

Text 10.1007_s00117-018-0478-1ebner.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (387kB) | Preview

CLINICAL/METHODICAL ISSUE

The National Lung Screening Trial (NLST) in 2011 was able to prove for the first time that screening with a low-dose CT can reduce lung carcinoma mortality by 20%. Despite the positive outcome of the NLST, there is-unlike in the USA-currently no systematic lung cancer screening in Europe. This is partly because several significantly smaller screening studies in Europe failed to show any improvement in lung cancer mortality.

STANDARD RADIOLOGICAL METHODS

On the other hand, Europe's healthcare systems differ substantially from those in the United States, so that a direct transfer of US experience to Europe is not possible. For this reason, guidelines for lung cancer screening must be developed in the individual European countries to ensure that lung cancer mortality can be reduced by means of a quality-assured and cost-effective lung cancer screening.

PRACTICAL RECOMMENDATIONS

The experience and the expected results of the European screening studies can provide valuable help for these purposes.

Interest & Impact

Downloads

302 since deposited on 12 Apr 2019
14 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item